Navigation Links
Robbins & Myers Reports Record Third Quarter Results
Date:6/30/2008

Total $200,946 $171,428 $559,414 $488,359

Income Before Interest and

Income Taxes (EBIT)

Fluid Management $25,230 $20,585 $64,648 $53,010

Process Solutions 10,184 5,261 25,614 21,413

Romaco 7,906 1,163 11,557 (4,109)

Corporate and Eliminations (3,160) (4,009) (12,217) (12,357)

Total $40,160 $23,000 $89,602 $57,957

Depreciation and Amortization

Fluid Management $1,839 $1,698 $5,023 $5,116

Process Solutions 1,803 1,647 5,158 4,855

Romaco 496 472 1,378 1,507

Corporate and Eliminations 148 166 503 682

Total $4,286 $3,983 $12,062 $12,160

Orders

Fluid Management $86,901 $75,067 $243,905 $221,535

Process Solutions 84,271 78,018 255,670 212,969

Romaco 34,115 32,968 115,623 96,640

Total $205,287 $186,053 $615,198 $531,144

Backlog

Fluid Management $54,493 $46,597 $54,493 $46,597

Process Solutions 141,678 107,091 $141,678 107,091

Romaco 71,763 58,463 $71,763 58,463

Total $267,934 $212,151 $267,934 $212,151

Robbins & Myers, Inc. and Subsidiaries

Reconciliation of Net Income to the non-GAAP measures of EBIT, EBITDA,

Adjusted EBIT and Adjusted EBITDA

(Unaudited)

Three Months Ended Nine Months Ended

May 31, May 31, May 31, May 3
'/>"/>

SOURCE Robbins & Myers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call
2. Robbins & Myers Reports Additional Gain and Increases Earnings Guidance
3. Robbins & Myers Schedules Second Quarter Fiscal 2008 Financial Results Conference Call
4. Robbins & Myers to Present at Gabelli Conference
5. Robbins & Myers to Present at Merrill Lynch Growth Industrials Conference December 13, 2007
6. Robbins & Myers Presenting at Bear Stearns 3rd Annual Commodities and Capital Goods Conference November 28, 2007
7. Robbins Bros. Gives Water at AIDS Walk L.A.
8. Robbins & Myers Announces Regular Quarterly Cash Dividend
9. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
10. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
11. Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer to have ... Surgery, according to a new survey that also offers insight on why that ... – which reflects views on cosmetic medical treatments and ratings for 10 specific ...
(Date:9/1/2015)... ... September 01, 2015 , ... Negative pressure ... inside a wound to remove exudates, fluid, and infectious materials to prepare the ... stand-alone devices, disposable devices, and canisters, etc.) is projected to expand continuously through ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... top-five hospital by U.S. News & World Report, to provide breaking news and ... Editorial and marketing groups within OncLive, which provides oncologists resources and information?they need ...
(Date:9/1/2015)... ... September 01, 2015 , ... PetPace, the provider ... vital signs and activity, today announced its integration with leading veterinary Practice Management ... widely-adopted veterinary hospital Practice Management Software packages in the US. Practice Management Software ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... of version 5.2 of the FirstSpirit Content Management System with new capabilities and ... new version of FirstSpirit, companies will be well on their way to achieving ...
Breaking Medicine News(10 mins):Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3
... working in the radiological department is a grave problem. ... the Department of Diagnostic Radiology // at the University ... new technique to help doctors. He has developed a ... allow them to perform their routine job at the ...
... health service is losing more than ?50m because of people ... of similar complaint by NHS managers the situation is now ... Huntingdon said: ‘Some people do not turn up as they ... a lot of problems in lost capacity and extra work.’ ...
... has shown that cutting back a few calories from our ... certain age related changes in cells. // ... found that eating a little less food and exercising a ... aging-related cell and organ damage in rats. ...
... examining Budhia Singh has suggested that he goes ‘slow’ and ... sometime//. ,A warrant-cum-authorization letter from the Khurda district welfare ... hospital. ,The medical panel headed by the ... boy’s serum urea, potassium and ALKP (alkaline phosphatase) levels to ...
... the doses given to children differ greatly from that ... much is enough for children//. A pair of studies ... dosage a computerized affair could greatly help children and ... calculator and a computerized drug ordering system, developed under ...
... cannot go to school because their parents fear that sending ... states a World Bank report. ,"The net primary enrolment ... 45 percent. As the girls transit to middle school, there ... few girls go on to complete middle school and very, ...
Cached Medicine News:Health News:Cut Calories to Age Gracefully 2Health News:Cut Calories to Age Gracefully 3Health News:Budhia's Medical Report Fails to Address Long Term Health Issues 2Health News:Dispensing Drug Dosage To Children Through Computers 2Health News:Dispensing Drug Dosage To Children Through Computers 3Health News:Dispensing Drug Dosage To Children Through Computers 4Health News:‘Family Honour’ Hinder Pakistani Girls In Getting Educati 2
(Date:9/1/2015)... Calif. and BRUSSELS ... AMGN ) and UCB (Euronext Brussels: UCB) today ... evaluating effect of RomosozUmab Compared with Teriparatide in ... fracture pReviously treated with bisphosphonatE therapy). The study ... significant difference in favor of romosozumab in the ...
(Date:9/1/2015)... Sept. 1, 2015 Emerus Holdings, a ... emergent, inpatient and diagnostic care in partnership with ... a definitive agreement to receive a strategic investment ... a leading health care investment firm. ... patient-centric acute episodic and ambulatory clinical services to ...
(Date:9/1/2015)... IRVINE, Calif. , Sept. 1, 2015  Edwards ... in the science of heart valves and hemodynamic monitoring, ... Fargo Healthcare Conference at the Hyatt Regency Boston in ... 9, 2015. Michael A. Mussallem , ... keynote lunch speaker followed by a company discussion with ...
Breaking Medicine Technology:Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 2Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 3Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 4Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 5Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 6Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 7Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 8Amgen And UCB Announce Positive Top-Line Results From Open-Label Phase 3 Study Of Romosozumab Compared With Teriparatide 9Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: ... emerging leader in the development, assembly, marketing and sale ... that the Company,s growing business earned a BBB+ Credit Rating ... "Zhongguancun Association") and was approved as a member of ...
... SHANGHAI, Feb. 28, 2012 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: ... China-based pharmaceutical and biotechnology research and development outsourcing company, ... results for the fourth quarter and full year ended ... host a conference call to discuss the results at ...
Cached Medicine Technology:Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 2Dehaier Medical Awarded Strong Credit Rating From Beijing Zhongguancun Enterprises Credit Promotion Association 3ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 13, 2012 2
Reptilase-Time from Bothrops atrox...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Pefakit TAFI Calibrators and Controls...
Plasma Control Level 2 - 1 ml...
Medicine Products: